Poster can be found in location 139.

Aims: The use of patient-reported outcome measures (PROMS) in medical research is widespread but there is little understanding of how PROMS could be used to improve patient choice and participation in treatment decisions. A recent study of PROMS related to high-risk medical implants conducted by the European CORE-MD (Coordinating Research and Evidence for Medical Devices) group allows us to examine how PROMS are currently being used and how they could be used to promote greater person-centred care. Methods: A systematic literature review of MEDLINE, CINAHL, the Cochrane trials databases (January 2000–June 2022) was conducted for PROMs used in orthopedic, cardiovascular and diabetes medical implant research. English-language articles reporting randomized or observational trials of implant surgeries with at least three months follow-up were retrieved. In addition, an online Delphi study and focus group was carried out together with the European Patient Forum, as the patient partner organization, of users of high-risk medical devices across Europe. Results: 410 articles were identified (Orthopedics = 205; Cardiovascular = 169; Diabetes = 236). A full-text review was conducted by four independent researchers, resulting in 117 papers for full-text analysis (Orthopedics = 44, Cardiovascular = 38, Diabetes = 35). The most frequently used PROMs were the generic measures of EQ-5D and SF-12 or SF36. Satisfaction or experience measures were almost exclusively presented in the form of a visual analogue scale. None of the studies reported having consulted the patient in the choice of PROM instrument and discussion of results. Conclusion: PROMS have the potential to act as a method of clinical communication between the patient and the health professional but also as feedback to manufacturers of medical devices. The issue of satisfaction with treatment emerged as an important domain from the patient perspective but lacked adequate definition and standardization of measurement.